Skip to main content

Advertisement

SpringerLink
Log in

Glycation free adduct accumulation in renal disease: the new AGE

  • Editorial Commentary
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Glycation adducts formed in the later stages of protein glycation reactions, advanced glycation endproducts (AGEs), are a class of uraemic toxin. Protein glycation was viewed originally as a post-translational modification that accumulated mostly on extracellular proteins. We now know that AGE residues are also formed on short-lived cellular and extracellular proteins. Cellular proteolysis forms AGE free adducts from these proteins, which are released into plasma for urinary excretion. AGE free adducts are also absorbed from food. AGE free adducts are the major molecular form by which AGEs are excreted in urine. They normally have high renal clearance, but this declines markedly in chronic renal failure patients, leading to profound increases in plasma AGE free adducts. Accumulation of plasma AGE free adducts is increased further in end stage renal disease patients on peritoneal dialysis and haemodialysis by increased AGE formation. The impact of AGEs absorbed from food is probably most marked for undialysed patients with mild uraemia. The toxicity of AGEs has been associated with resistance of the extracellular matrix to proteolysis and AGE receptor-mediated responses. AGE free adducts may also contribute to vascular disease in uraemia. They represent an important new age for glycation research in nephrology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Thornalley PJ (1999) Clinical significance of glycation. Clin Lab 45:263–273

    Google Scholar 

  2. Thornalley PJ, Battah S, Ahmed N, Karachalias N, Agalou S, Babaei-Jadidi R, Dawnay A (2003) Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 375:581–592

    Article  PubMed  Google Scholar 

  3. Hammes H-P, Brownlee M, Liu J, Schleicher E, Bretzel RG (1999) Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nε-(carboxymethyl)lysine independently of glycohaemoglobin concentrations. Diabetologia 42:603–607

    Article  PubMed  Google Scholar 

  4. Sebekova K, Podracka L, Blazicek P, Syrova D, Heidland A, Schinzel R (2001) Plasma levels of advanced glycation end products in children with renal disease. Pediatr Nephrol 16:1105–1112

    Article  PubMed  Google Scholar 

  5. Fukunaga Y, Katsuragi Y, Izumi T, Sakiyama F (1982) Fluorescence characteristics of kynurenine and N′-formylkynurenine. Their use as reporters of the environment of tryptophan 62 in hen egg-white lysozyme. J Biochem 92:129–141

    PubMed  Google Scholar 

  6. Odetti P, Fogarty J, Sell DR, Monnier VM (1992) Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 41:153–159

    PubMed  Google Scholar 

  7. Wilker SC, Chellan P, Arnold BM, Nagaraj RH (2001) Chromatographic quantification of argpyrimidine, a methylglyoxal-derived product in tissue proteins. Anal Biochem 290:353–358

    Article  PubMed  Google Scholar 

  8. Verzijl N, DeGroot J, Thorpe SR, Bank RA, Shaw JN, Lyons TJ, Bijlsma JWJ, Lafeberi FPJG, Baynes JW, TeKoppele JM (2000) Effect of collagen turnover on the accumulation of advanced glycation endproducts. J Biol Chem 275:39027–39031

    Article  PubMed  Google Scholar 

  9. Goldberg AL (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426:895–899

    Article  PubMed  Google Scholar 

  10. Gerner C, Vejda S, Gelbmann D, Bayer E, Gotzmann J, Schulte-Hermann R, Mikulitis W (2002) Concomitant determination of absolute values of cellular protein amounts, synthesis rates, and turnover rates by quantitative proteome profiling. Mol Cell Proteomics 1:528–537

    Article  PubMed  Google Scholar 

  11. Agalou S, Ahmed N, Babaei-Jadidi R, Dawnay A, Thornalley PJ (2005) Profound mishandling of protein glycation degradation products in uremia and dialysis. J Am Soc Nephrol 16:1471–1485

    Article  PubMed  Google Scholar 

  12. Suzuki D, Miyata T, Saotome N, Horie K, Inagi R, Yasuda Y, Uchida K, Izuhara Y, Yagame M, Sakai H, Kurokawa K (1999) Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J Am Soc Nephrol 10:822–832

    PubMed  Google Scholar 

  13. Delpierre G, Vertommen D, Communi D, Rider MH, Van Schaftingen E (2004) Identification of fructosamine residues deglycated by fructosamine-3-kinase in human hemoglobin. J Biol Chem 279:27613–27620

    Article  PubMed  Google Scholar 

  14. Szwergold BS, Howell S, Beisswenger PJ (2001) Human fructosamine-3-kinase. Purification, sequencing, substrate specificity, and evidence of activity in vivo. Diabetes 50:2139–2147

    PubMed  Google Scholar 

  15. Delpierre G, Collard F, Fortpied J, Van Schaftingen E (2002) Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes. Biochem J 365:801–808

    PubMed  Google Scholar 

  16. Layton GJ, Allen TJ, Jerums G (1990) Longitudinal evaluation of the renal clearance of glycated albumin in the diabetic rat. Diabetes Res Clin Pract 8:221–226

    Article  PubMed  Google Scholar 

  17. Takahashi M, Fujii J, Teshima T, Suzuki K, Shiba T, Taniguchi N (1993) Identity of a major 3-deoxyglucosone-reducing enzyme with aldehyde reductase in rat liver established by amino acid sequencing and cDNA expression. Gene 127:249–253

    Article  PubMed  Google Scholar 

  18. Ahmed N, Dobler D, Dean M, Thornalley PJ (2005) Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity. J Biol Chem 280:5724–5732

    Article  PubMed  Google Scholar 

  19. Thornalley PJ (2003) Glyoxalase I—structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans 31:1343–1348

    PubMed  Google Scholar 

  20. Ahmed N, Argirov OK, Minhas HS, Cordeiro CA, Thornalley PJ (2002) Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatisation by aminoquinolyl-N-hydroxysuccimidyl-carbamate and application to Nε-carboxymethyl-lysine- and Nε-(1-carboxyethyl)lysine-modified albumin. Biochem J 364:1-14

    PubMed  Google Scholar 

  21. Gallet X, Charloteaux B, Thomas A, Braseur R (2000) A fast method to predict protein interaction sites from sequences. J Mol Biol 302:917–926

    Article  PubMed  Google Scholar 

  22. Ahmed N, Thornalley PJ, Dawczynski J, Franke S, Strobel J, Stein G, Haik JR GM (2003) Methylglyoxal-derived hydroimidazolone advanced glycation endproducts of human lens proteins. Invest Ophthalmol Vis Sci 44:5287–5292

    Article  PubMed  Google Scholar 

  23. Thornalley PJ (2005) Dicarbonyl intermediates in the Maillard reaction. Ann N Y Acad Sci 1043:118

    Google Scholar 

  24. Thornalley PJ, Argirova M, Ahmed N, Mann VM, Argirov OK, Dawnay A (2000) Mass spectrometric monitoring of albumin in uraemia. Kidney Int 58:2228–2234

    Article  PubMed  Google Scholar 

  25. Ahmed N, Thornalley PJ (2002) Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatisation with aminoquinolyl-N-hydroxysuccimidyl-carbamate and intrinsic fluorescence. Biochem J 364:15–24

    PubMed  Google Scholar 

  26. Henle T (2003) AGEs in foods: do they play a role in uremia? Kidney Int 63:S145–S147

    Article  Google Scholar 

  27. Johnson RN, Easdale RW, Tatnell M, Baker JR (1991) Significance of variation in turnover of glycated albumin on indexes of diabetic control. Clin Chim Acta 198:229–238

    Article  PubMed  Google Scholar 

  28. Ahmed N, Thornalley PJ, Luthen R, Haussinger D, Sebekova K, Schinzel R, Voelker W, Heidland A (2004) Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis. J Hepatol 41:913–919

    Article  PubMed  Google Scholar 

  29. Russo LM, Bakris GL, Comper WD (2002) Renal handling of albumin: a critical review of basic concepts and perspective. Am J Kidney Dis 39:899–919

    Article  PubMed  Google Scholar 

  30. Cha T, Tahara Y, Yamoto E, Yoneda H, Ikegami H, Noma Y, Shima K, Ogihara T (1991) Renal handling of glycated albumin in non-insulin-dependent diabetes mellitus with nephropathy. Diabetes Res Clin Pract 12:149–156

    Article  PubMed  Google Scholar 

  31. Bendayan M, Londono I (1996) Reabsorption of native and glycated albumin by renal proximal tubular epithelial cells. Am J Physiol 40:F261–F268

    Google Scholar 

  32. Greive KA, Balazs NDH, Comper WD (2001) Protein fragments in urine have been considerably underestimated by various protein assays. Clin Chem 47:1717–1719

    PubMed  Google Scholar 

  33. Ahmed N, Babaei-Jadidi R, Howell SK, Beisswenger PJ, Thornalley PJ (2005) Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes. Diabetologia (in press)

  34. Koschinsky T, He C-J, Mitsuhashi T, Bucala R, Liu C, Buenting C, Heitman K, Vlassara H (1997) Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci U S A 94:6474–6479

    Google Scholar 

  35. Cai WJ, Gao QD, Zhu L, Peppa M, He CJ, Vlassara H (2002) Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction. Mol Med 8:337–346

    PubMed  Google Scholar 

  36. Vlassara H, Cai WJ, Crandall J, Goldberg T, Oberstein R, Dardaine V, Peppa M, Rayfield EJ (2002) Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci U S A 99:15596–15601

    Google Scholar 

  37. Uribarri J, Peppa M, Cai WJ, Goldberg T, Lu M, Baliga S, Vassalotti JA, Vlassara H (2003) Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients. Am J Kidney Dis 42:532–538

    Article  PubMed  Google Scholar 

  38. Ahmed N, Mirshekar-Syahkal B, Kennish L, Karachalias N, Babaei-Jadidi R, Thornalley PJ (2005) Assay of advanced glycation endproducts in selected beverages and food by liquid chromatography with tandem mass spectrometric detection. Mol Nutr Food Res 49:691–699

    Article  PubMed  Google Scholar 

  39. He C, Sabol J, Mitsuhashi T, Vlassara H (1999) Dietary glycotoxins. Inhibition of reactive products by aminoguanidine facilitates renal clearance and reduced tissue sequestration. Diabetes 48:1308–1315

    PubMed  Google Scholar 

  40. Thornalley PJ, Langborg A, Minhas HS (1999) Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 344:109–116

    Article  PubMed  Google Scholar 

  41. Thornalley PJ (2003) Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch Biochem Biophys 419:31–40

    Article  PubMed  Google Scholar 

  42. Thornalley PJ (1988) Modification of the glyoxalase system in human red blood cells by glucose in vitro. Biochem J 254:751–755

    PubMed  Google Scholar 

  43. Nagao M, Fujita Y, Sugimura T, Kosuge T (1986) Methylglyoxal in beverages and foods its mutagenicity and carcinogenicity. IARC Sci Publ 70:283–291

    PubMed  Google Scholar 

  44. Hayashi T, Shibamoto T (1985) Analysis of methylglyoxal in foods and beverages. J Agric Food Chem 33:1090–1093

    Article  Google Scholar 

  45. Mortier S, Faict D, Schalkwijk CG, Lameire NH, De Vriese AS (2004) Long-term exposure to new peritoneal dialysis solutions: effects on the peritoneal membrane. Kidney Int 66:1257–1265

    Article  PubMed  Google Scholar 

  46. Oste RE, Miller R, Sjostrom H, Noren O (1987) Effect of Maillard reaction products on protein digestion—studies on pure compounds. J Agric Food Chem 35:938–942

    Article  Google Scholar 

  47. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S (2002) Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346:802–810

    Article  PubMed  Google Scholar 

  48. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, UK Prospective Diabetes Study Group (2003) Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63:225–252

    Article  PubMed  Google Scholar 

  49. Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, Thornalley PJ (2003) Prevention of incipient diabetic nephropathy by high dose thiamine and Benfotiamine. Diabetes 52:2110–2120

    PubMed  Google Scholar 

  50. Litwin M, Wuhl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Troger J, Mehls O, Schaefer F (2005) Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 16:1494–1500

    Article  PubMed  Google Scholar 

  51. Chavers BM, Li S, Collins AJ, Herzog CA (2002) Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int 62:648–653

    Article  PubMed  Google Scholar 

  52. Misselwitz J, Franke S, Kauf E, John U, Stein G (2002) Advanced glycation end products in children with chronic renal failure and type 1 diabetes. Pediatr Nephrol 17:316–321

    Article  PubMed  Google Scholar 

  53. Bayazit AK, Vogt BA, Dell KM, Davis ID, Noyan A, Anarat A, Avner ED, Erhard P, Weiss MF (2003) Effect of the peritoneal dialysis prescription on pentosidine in children. Pediatr Nephrol 18:1049–1054

    Article  PubMed  Google Scholar 

  54. Sebekova K, Podracka L, Heidland A, Schinzel R (2001) Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation—are they inter-related? Clin Nephrol 56:S21–S26

    PubMed  Google Scholar 

  55. Flynn JT (2002) Choice of dialysis modality for management of pediatric acute renal failure. Pediatr Nephrol 17:61–69

    Article  PubMed  Google Scholar 

  56. Leonard MB, Donaldson LA, Ho M, Geary DF (2003) A prospective cohort study of incident maintenance dialysis in children: an NAPRTC study. Kidney Int 63:744–755

    Article  PubMed  Google Scholar 

  57. Schroder CH (2001) The choice of dialysis solutions in pediatric chronic peritoneal dialysis: guidelines by an ad hoc European committee. Perit Dial Int 21:568–574

    PubMed  Google Scholar 

  58. Deguchi T, Kusuhara H, Takadate A, Endou H, Otagiri M, Sugiyama Y (2004) Characterization of uremic toxin transport by organic anion transporters in the kidney. Kidney Int 65:162–174

    Article  PubMed  Google Scholar 

  59. Mann GE, Yudilevich DL, Sobrevia L (2003) Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 83:183–252

    PubMed  Google Scholar 

  60. Deuther-Conrad W, Franke S, Sommer M, Henle T, Stein G (2001) Differences in the modulating potential of advanced glycation (AGE) peptides versus AGE proteins. Kidney Int 59:S63–S66

    Article  Google Scholar 

  61. Yoshihara K, Okumura T, Yoshida T, Beppu M (2001) Inhibitory effect of peptide-free forms of advanced glycation end products on the proliferation and extracellular matrix protein production of cultured cells. J Health Sci 47:296–301

    Article  Google Scholar 

  62. Thornalley PJ (1998) Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol Biol 44:1013–1023

    PubMed  Google Scholar 

  63. Thornalley PJ (2004) Glycation, receptor-mediated cell activation and vascular complications of diabetes. Diabetes Vasc Dis Res 1:21–22

    Google Scholar 

  64. Kuzuya M, Asai T, Kanda S, Maeda K, Cheng XW, Iguchi A (2001) Glycation cross-links inhibit matrix metalloproteinase-2 activation in vascular smooth muscle cells cultured on collagen lattice. Diabetologia 44:436

    Article  Google Scholar 

  65. Lindsay RM, Nesrallah G, Suri R, Garg A, Moist L (2004) Is more frequent hemodialysis beneficial and what is the evidence? Curr Opinion Nephrol Hypertens 13:631–635

    Article  Google Scholar 

Download references

Acknowledgements

I thank the Wellcome Trusts and Baxter Healthcare Inc. (Illinois, USA) for support for my uraemia research.

Author information

Authors and Affiliations

  1. Department of Biological Sciences, University of Essex, Wivenhoe Park, Colchester, Essex, CO4 3SQ, UK

    Paul J. Thornalley

Authors
  1. Paul J. Thornalley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul J. Thornalley.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thornalley, P.J. Glycation free adduct accumulation in renal disease: the new AGE. Pediatr Nephrol 20, 1515–1522 (2005). https://doi.org/10.1007/s00467-005-2011-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-005-2011-9

Keywords

Search

Navigation